Gerben Duns

1.7k total citations
22 papers, 619 citations indexed

About

Gerben Duns is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Gerben Duns has authored 22 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Gerben Duns's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (3 papers). Gerben Duns is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (3 papers). Gerben Duns collaborates with scholars based in Canada, Netherlands and United States. Gerben Duns's co-authors include Klaas Kok, Anke van den Berg, Robert M.W. Hofstra, Harry Hollema, Helga Westers, Rolf H. Sijmons, Jun Li, Debora de Jong, Aly Karsan and Monika Hudoba and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Gerben Duns

20 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerben Duns Canada 10 463 218 140 73 70 22 619
Angela Tam United States 9 426 0.9× 71 0.3× 159 1.1× 115 1.6× 48 0.7× 12 634
Takeshi Niinuma Japan 17 617 1.3× 388 1.8× 132 0.9× 120 1.6× 90 1.3× 39 872
Liping Chung Australia 14 270 0.6× 119 0.5× 93 0.7× 158 2.2× 60 0.9× 20 555
Tara M. Lichtenberg United States 3 346 0.7× 193 0.9× 77 0.6× 150 2.1× 37 0.5× 7 635
Eliseo Mattioli Italy 14 233 0.5× 83 0.4× 102 0.7× 129 1.8× 41 0.6× 19 465
Seung‐Moo Noh South Korea 20 583 1.3× 305 1.4× 198 1.4× 175 2.4× 64 0.9× 33 970
Tiantian Zhen China 12 328 0.7× 259 1.2× 113 0.8× 131 1.8× 68 1.0× 27 525
Kristy Miskimen United States 13 392 0.8× 208 1.0× 114 0.8× 262 3.6× 47 0.7× 31 634
Yasuyuki Gen Japan 19 583 1.3× 277 1.3× 190 1.4× 189 2.6× 68 1.0× 30 857

Countries citing papers authored by Gerben Duns

Since Specialization
Citations

This map shows the geographic impact of Gerben Duns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerben Duns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerben Duns more than expected).

Fields of papers citing papers by Gerben Duns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerben Duns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerben Duns. The network helps show where Gerben Duns may publish in the future.

Co-authorship network of co-authors of Gerben Duns

This figure shows the co-authorship network connecting the top 25 collaborators of Gerben Duns. A scholar is included among the top collaborators of Gerben Duns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerben Duns. Gerben Duns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bridgers, Joshua, Shujun Huang, Barbara Meissner, et al.. (2024). Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing. Clinical Chemistry. 70(1). 273–284. 2 indexed citations
2.
Li, Michael Y., Lauren C. Chong, Gerben Duns, et al.. (2024). TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences. 121(18). e2320421121–e2320421121. 7 indexed citations
3.
Rafiei, Hossein, Michelle Yeung, Michael Y. Li, et al.. (2024). Butyrate and tributyrin reduce LPS-induced inflammatory cytokine production from human visceral fat. International Journal of Obesity. 48(11). 1559–1567. 2 indexed citations
4.
Cooper, Alan, Girish Venkataraman, Joo Y. Song, et al.. (2023). CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition. Journal of Clinical Oncology. 42(4). 467–480. 10 indexed citations
5.
Cooper, Alan, Girish Venkataraman, Joo Y. Song, et al.. (2023). A CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition. Blood. 142(Supplement 1). 851–851. 2 indexed citations
6.
Duns, Gerben, Lisa M. Rimsza, Karen L. Rech, et al.. (2022). Transformation of FL into DLBCL with a PMBL gene expression signature. Blood Advances. 7(6). 893–899. 1 indexed citations
7.
Mo, Angela, Xuan Wang, Linda Chang, et al.. (2022). Loss of FBXO11 Function Establishes a Stem Cell Program in Acute Myeloid Leukemia through Dysregulation of the Mitochondrial Protease LONP1. Blood. 140(Supplement 1). 8688–8689. 1 indexed citations
8.
Winkle, Melanie, Klaas Kok, Gerben Duns, et al.. (2022). The lncRNA KTN1-AS1 co-regulates a variety of Myc-target genes and enhances proliferation of Burkitt lymphoma cells. Human Molecular Genetics. 31(24). 4193–4206. 11 indexed citations
9.
Hilton, Laura K., Kostiantyn Dreval, Susana Ben‐Neriah, et al.. (2021). Constrained FL: A Genetically Distinct Subgroup of Follicular Lymphoma with Low Rates of Somatic Hypermutation and a Reduced Propensity for Histologic Transformation. Blood. 138(Supplement 1). 807–807.
10.
Sarkozy, Clémentine, Lauren C. Chong, Katsuyoshi Takata, et al.. (2020). Gene expression profiling of gray zone lymphoma. Blood Advances. 4(11). 2523–2535. 22 indexed citations
11.
Duns, Gerben, Elena Viganò, Daisuke Ennishi, et al.. (2019). Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome. Blood. 134(Supplement_1). 922–922. 1 indexed citations
12.
Mo, Angela, Linda Chang, Gerben Duns, et al.. (2019). LOSS OF FBXO11 FUNCTIONS DRIVES ACUTE MYELOID LEUKEMIA. Experimental Hematology. 76. S78–S78. 4 indexed citations
13.
Foroushani, Amir, Roderick Docking, Linda Chang, et al.. (2018). Applications of Bayesian network models in predicting types of hematological malignancies. Scientific Reports. 8(1). 6951–6951. 48 indexed citations
14.
15.
Li, Jun, Gerben Duns, Helga Westers, et al.. (2016). SETD2: an epigenetic modifier with tumor suppressor functionality. Oncotarget. 7(31). 50719–50734. 113 indexed citations
16.
Duns, Gerben, Robert M.W. Hofstra, Harry Hollema, et al.. (2012). Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development. Human Mutation. 33(7). 1059–1062. 57 indexed citations
17.
Duns, Gerben, Anke van den Berg, Marcory C. R. F. van Dijk, et al.. (2012). The entire miR‐200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney. Genes Chromosomes and Cancer. 52(2). 165–173. 25 indexed citations
18.
Duns, Gerben, et al.. (2010). Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma. Cancer Research. 70(11). 4287–4291. 187 indexed citations
19.
Duns, Gerben, Debora de Jong, Ody C.M. Sibon, et al.. (2009). A high throughput experimental approach to identify miRNA targets in human cells. Nucleic Acids Research. 37(20). e137–e137. 92 indexed citations
20.
Kroesen, Bart‐Jan, Enrico Tiacci, Gerben Duns, et al.. (2009). Contribution of Deregulated miRNAs to the Phenotypic Characteristic of Hodgkin Lymphoma.. Blood. 114(22). 265–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Tam Breakdown of academic impact, for papers by Takeshi Niinuma Breakdown of academic impact, for papers by Liping Chung Breakdown of academic impact, for papers by Tara M. Lichtenberg Breakdown of academic impact, for papers by Eliseo Mattioli Breakdown of academic impact, for papers by Seung‐Moo Noh Breakdown of academic impact, for papers by Tiantian Zhen Breakdown of academic impact, for papers by Kristy Miskimen Breakdown of academic impact, for papers by Yasuyuki Gen
Rankless by CCL
2026